186 related articles for article (PubMed ID: 11148050)
1. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis.
Zhitkovich A; Song Y; Quievryn G; Voitkun V
Biochemistry; 2001 Jan; 40(2):549-60. PubMed ID: 11148050
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
Quievryn G; Peterson E; Messer J; Zhitkovich A
Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
[TBL] [Abstract][Full Text] [Related]
3. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage.
Zhitkovich A; Shrager S; Messer J
Chem Res Toxicol; 2000 Nov; 13(11):1114-24. PubMed ID: 11087433
[TBL] [Abstract][Full Text] [Related]
4. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
Zhitkovich A; Quievryn G; Messer J; Motylevich Z
Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121
[TBL] [Abstract][Full Text] [Related]
5. Reduction of Cr (VI) by cysteine: significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates.
Quievryn G; Goulart M; Messer J; Zhitkovich A
Mol Cell Biochem; 2001 Jun; 222(1-2):107-18. PubMed ID: 11678591
[TBL] [Abstract][Full Text] [Related]
6. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells.
Voitkun V; Zhitkovich A; Costa M
Nucleic Acids Res; 1998 Apr; 26(8):2024-30. PubMed ID: 9518499
[TBL] [Abstract][Full Text] [Related]
7. Characterization of nonmutagenic Cr(III)-DNA interactions.
Blankert SA; Coryell VH; Picard BT; Wolf KK; Lomas RE; Stearns DM
Chem Res Toxicol; 2003 Jul; 16(7):847-54. PubMed ID: 12870887
[TBL] [Abstract][Full Text] [Related]
8. Reduction with glutathione is a weakly mutagenic pathway in chromium(VI) metabolism.
Guttmann D; Poage G; Johnston T; Zhitkovich A
Chem Res Toxicol; 2008 Nov; 21(11):2188-94. PubMed ID: 18808157
[TBL] [Abstract][Full Text] [Related]
9. Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate.
Quievryn G; Messer J; Zhitkovich A
Carcinogenesis; 2006 Nov; 27(11):2316-21. PubMed ID: 16714765
[TBL] [Abstract][Full Text] [Related]
10. Induction of mutagenic DNA damage by chromium (VI) and glutathione.
Liu S; Dixon K
Environ Mol Mutagen; 1996; 28(2):71-9. PubMed ID: 8844987
[TBL] [Abstract][Full Text] [Related]
11. Sequence specificity of Cr(III)-DNA adduct formation in the p53 gene: NGG sequences are preferential adduct-forming sites.
Arakawa H; Wu F; Costa M; Rom W; Tang MS
Carcinogenesis; 2006 Mar; 27(3):639-45. PubMed ID: 16251206
[TBL] [Abstract][Full Text] [Related]
12. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells.
Quievryn G; Messer J; Zhitkovich A
Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455
[TBL] [Abstract][Full Text] [Related]
13. Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity.
Reynolds M; Peterson E; Quievryn G; Zhitkovich A
J Biol Chem; 2004 Jul; 279(29):30419-24. PubMed ID: 15087443
[TBL] [Abstract][Full Text] [Related]
14. Mutational spectrum induced by chromium(III) in shuttle vectors replicated in human cells: relationship to Cr(III)-DNA interactions.
Tsou TC; Lin RJ; Yang JL
Chem Res Toxicol; 1997 Sep; 10(9):962-70. PubMed ID: 9305577
[TBL] [Abstract][Full Text] [Related]
15. Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group.
Zhitkovich A; Voitkun V; Costa M
Biochemistry; 1996 Jun; 35(22):7275-82. PubMed ID: 8679557
[TBL] [Abstract][Full Text] [Related]
16. Mutagenicity of DNA adducts derived from ethylene oxide exposure in the pSP189 shuttle vector replicated in human Ad293 cells.
Tompkins EM; McLuckie KI; Jones DJ; Farmer PB; Brown K
Mutat Res; 2009 Aug; 678(2):129-37. PubMed ID: 19477295
[TBL] [Abstract][Full Text] [Related]
17. Examining the Potential Formation of Ternary DNA Complexes with Chromium‑Cysteine, Chromium-Ascorbate, and Chromium-Glutathione and Implications for Their Carcinogenicity.
Marchi S; Lankford E; Dorin B; Drummond E; Thomas SC; Woski SA; Vincent JB
Biol Trace Elem Res; 2023 Oct; 201(10):5053-5066. PubMed ID: 36662348
[TBL] [Abstract][Full Text] [Related]
18. Chromium (VI) induces both bulky DNA adducts and oxidative DNA damage at adenines and guanines in the p53 gene of human lung cells.
Arakawa H; Weng MW; Chen WC; Tang MS
Carcinogenesis; 2012 Oct; 33(10):1993-2000. PubMed ID: 22791815
[TBL] [Abstract][Full Text] [Related]
19. Chromium(VI) enhances (+/-)-anti-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene-induced cytotoxicity and mutagenicity in mammalian cells through its inhibitory effect on nucleotide excision repair.
Hu W; Feng Z; Tang MS
Biochemistry; 2004 Nov; 43(44):14282-9. PubMed ID: 15518579
[TBL] [Abstract][Full Text] [Related]
20. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions.
O'Brien T; Mandel HG; Pritchard DE; Patierno SR
Biochemistry; 2002 Oct; 41(41):12529-37. PubMed ID: 12369844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
